Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Bioxytran (BIXT) EV to CFO (2013 - 2018)

Updated

Bioxytran's (BIXT) EV to CFO stood at 6011.27 in Q3 2018, up 152.0% from 2384.98 a year earlier and up 54.4% from the prior quarter.

Analysis

Bioxytran (BIXT) EV to CFO (2013 - 2018) Analysis & Trends

On a TTM basis, Bioxytran's EV to CFO came in at 6011.21 as of Sep 30, 2018, up 152.8% year-over-year; for FY2013, it was 1850129.14.

  • Quarterly EV to CFO has ranged from 2384.98 in Q3 2017 to 1850129.14 in Q4 2013 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 3892.68 (Q2 2018), 6192.46 (Q1 2018) and 6652.94 (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Bioxytran 2.29 Mn 1.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 6,011.27
Jun 30, 2018 3,892.68
Mar 31, 2018 6,192.46
Dec 31, 2017 6,652.94
Sep 30, 2017 2,384.98
Sep 30, 2014 666,095.49
Jun 30, 2014 449,786.13
Mar 31, 2014 288,156.86
Dec 31, 2013 1.85 Mn
API Access

Bioxytran EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=BIXT&period=max&api_key=YOUR_API_KEY